Sana Biotechnology, Inc.
Price Action
Technical Summary
WEAKENINGSana Biotechnology, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 45), showing significant lag compared to the market leaders. Earnings growth of 19% provides fundamental context to the price action. However, with RSI at 76, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.17 | +25.08% | ABOVE |
| 50 SMA | $3.22 | +23.36% | ABOVE |
| 100 SMA | $3.35 | +18.64% | ABOVE |
| 150 SMA | $3.74 | +6.20% | ABOVE |
| 200 SMA | $3.86 | +2.94% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SANA in an uptrend right now?
SANA has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is SANA overbought or oversold?
SANA's RSI (14) is 76. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is SANA outperforming the market?
SANA has a Relative Strength (RS) Rating of 45 out of 99. SANA is currently lagging the broader market.
Where is SANA in its 52-week range?
SANA is trading at $3.97, which is 61% of its 52-week high ($6.55) and 35% above its 52-week low ($2.61).
How volatile is SANA?
SANA has a Beta of 2.59 and 52-week volatility of 96%. It's more volatile than the S&P 500 - expect bigger swings.